These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 17905838)

  • 1. Enhancing the stability and solubility of TEV protease using in silico design.
    Cabrita LD; Gilis D; Robertson AL; Dehouck Y; Rooman M; Bottomley SP
    Protein Sci; 2007 Nov; 16(11):2360-7. PubMed ID: 17905838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unexpected tobacco etch virus (TEV) protease cleavage of recombinant human proteins.
    Beaumont LP; Mehalko J; Johnson A; Wall VE; Esposito D
    Protein Expr Purif; 2024 Aug; 220():106488. PubMed ID: 38679188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational design of a new mutant of tobacco etch virus protease in order to increase the
    Mohammadian H; Mahnam K; Sadeghi HM; Ganjalikhany MR; Akbari V
    Res Pharm Sci; 2020 Apr; 15(2):164-173. PubMed ID: 32582356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tobacco etch virus (TEV) protease with multiple mutations to improve solubility and reduce self-cleavage exhibits enhanced enzymatic activity.
    Nam H; Hwang BJ; Choi DY; Shin S; Choi M
    FEBS Open Bio; 2020 Apr; 10(4):619-626. PubMed ID: 32129006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incorporating a TEV cleavage site reduces the solubility of nine recombinant mouse proteins.
    Kurz M; Cowieson NP; Robin G; Hume DA; Martin JL; Kobe B; Listwan P
    Protein Expr Purif; 2006 Nov; 50(1):68-73. PubMed ID: 16798010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P1' specificity of the S219V/R203G mutant tobacco etch virus protease.
    Golda M; Hoffka G; Cherry S; Tropea JE; Lountos GT; Waugh DS; Wlodawer A; Tőzsér J; Mótyán JA
    Proteins; 2024 Sep; 92(9):1085-1096. PubMed ID: 38666764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production, purification and characterization of a double-tagged TEV protease.
    Rizza JD; Ortega C; Carrión F; Fló M; Correa A
    Protein Expr Purif; 2022 Mar; 191():106021. PubMed ID: 34798273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Covalent immobilization of tobacco-etch-virus NIa protease: a useful tool for cleavage of the histidine tag of recombinant proteins.
    Puhl AC; Giacomini C; Irazoqui G; Batista-Viera F; Villarino A; Terenzi H
    Biotechnol Appl Biochem; 2009 May; 53(Pt 3):165-74. PubMed ID: 18937642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tobacco etch virus protease: mechanism of autolysis and rational design of stable mutants with wild-type catalytic proficiency.
    Kapust RB; Tözsér J; Fox JD; Anderson DE; Cherry S; Copeland TD; Waugh DS
    Protein Eng; 2001 Dec; 14(12):993-1000. PubMed ID: 11809930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A SEP tag enhances the expression, solubility and yield of recombinant TEV protease without altering its activity.
    Nautiyal K; Kuroda Y
    N Biotechnol; 2018 May; 42():77-84. PubMed ID: 29448030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of solvent media to solubilize TEV protease using response surface method.
    Mohammadian N; Mohammadian H; Moazen F; Pakdel MH; Jahanian-Najafabadi A; Mir Mohammad Sadeghi H
    Res Pharm Sci; 2020 Aug; 15(4):331-339. PubMed ID: 33312211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering soluble tobacco etch virus protease accompanies the loss of stability.
    Fang J; Chen L; Cheng B; Fan J
    Protein Expr Purif; 2013 Nov; 92(1):29-35. PubMed ID: 24012464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An improved strategy for high-level production of TEV protease in Escherichia coli and its purification and characterization.
    Fang L; Jia KZ; Tang YL; Ma DY; Yu M; Hua ZC
    Protein Expr Purif; 2007 Jan; 51(1):102-9. PubMed ID: 16919473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acyl carrier protein tag can enhance tobacco etch virus protease stability and promote its covalent immobilisation.
    Li X; Huang J; Zhou J; Sun C; Zheng Y; Wang Y; Zhu J; Wang S
    Appl Microbiol Biotechnol; 2023 Mar; 107(5-6):1697-1705. PubMed ID: 36763116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved solubility of TEV protease by directed evolution.
    van den Berg S; Löfdahl PA; Härd T; Berglund H
    J Biotechnol; 2006 Feb; 121(3):291-8. PubMed ID: 16150509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel method for high-level production of TEV protease by superfolder GFP tag.
    Wu X; Wu D; Lu Z; Chen W; Hu X; Ding Y
    J Biomed Biotechnol; 2009; 2009():591923. PubMed ID: 20182554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo and in vitro characterization of TEV protease mutants.
    Wei L; Cai X; Qi Z; Rong L; Cheng B; Fan J
    Protein Expr Purif; 2012 Jun; 83(2):157-63. PubMed ID: 22484199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A combined approach to improving large-scale production of tobacco etch virus protease.
    Blommel PG; Fox BG
    Protein Expr Purif; 2007 Sep; 55(1):53-68. PubMed ID: 17543538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled intracellular processing of fusion proteins by TEV protease.
    Kapust RB; Waugh DS
    Protein Expr Purif; 2000 Jul; 19(2):312-8. PubMed ID: 10873547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of alkyl chain substitution of ammonium ionic liquids on the activity and stability of tobacco etch virus protease.
    Attri P; Choi S; Kim M; Shiratani M; Cho AE; Lee W
    Int J Biol Macromol; 2020 Jul; 155():439-446. PubMed ID: 32220643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.